| NCT ID | NCT06120907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Pruritus |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-18 |
| Primary Completion | 2033-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-10-18 with a primary completion date of 2033-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project is to develop a national registry for CP patients. Patients admitted to this registry will be examined and documented with PROs, physician-based assessments, blood tests, 3D photodocumentation and, if indicated, by skin biopsies, neurophysiological testing and radiological imaging at defined timepoints. The data collection will allow deepened insights into patient needs, different mechanisms and courses of pruritic conditions, treatment outcomes and treatment-related safety issues. In addition, the collection of clinical, biological and image-based data may be used for retrospective analyses.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 14 years. * Written informed consent of the patient. * Diagnosis of CP irrespective of the International Forum for the Study of Itch (IFSI) group (I-III) and/or underlying cause (according to the judgment of the investigator). * A Numerical Rating Scale (NRS) score of min. ≥ 4 within the last 7 days. * Sufficient language skills (in the languages which the patient information and the consent form is available) to provide informed consent. Exclusion Criteria: * Any medical or psychological condition in the treating physician's opinion, which may prevent the patient in registry participation * Lack of informed consent for registry participation. * Refusal to complete Patient Reported Outcomes (PROs)
Contact & Investigator
Simon Mueller, PD Dr. med.
PRINCIPAL INVESTIGATOR
Department of Dermatology, University Hospital Basel
Frequently Asked Questions
Who can join the NCT06120907 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying Pruritus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06120907 currently recruiting?
Yes, NCT06120907 is actively recruiting participants. Contact the research team at simon.mueller@usb.ch for enrollment information.
Where is the NCT06120907 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT06120907 clinical trial?
NCT06120907 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Simon Mueller, PD Dr. med. at Department of Dermatology, University Hospital Basel. The trial plans to enroll 100 participants.